Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 21 July, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo

Fundamental Analysis of Cipla Ltd

About the Company - Cipla Ltd

Cipla Ltd. is a Public Limited Listed company incorporated on 17/08/1935 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1935PLC002380 and registration number is 002380. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 13091.79 Cr. and Equity Capital is Rs. 161.36 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
PharmaceuticalsCipla House, Peninsula Business Park, Mumbai Maharashtra 400013cosecretary@cipla.com
http://www.cipla.com
Management
NamePosition Held
Dr. Y K HamiedChairman
Mr. M K HamiedVice Chairman
Ms. Samina HamiedExecutive Vice Chairman
Mr. Umang VohraManaging Director & Global CEO
Mr. S RadhakrishnanNon Exe.Non Ind.Director
Mr. Ashok SinhaIndependent Director
Mr. P R RameshIndependent Director
Mr. Robert StewartIndependent Director
Dr. Mandar VaidyaIndependent Director
Mr. Adil ZainulbhaiIndependent Director
Ms. Punita LalIndependent Director

Basic Stock Data of Cipla Ltd

Last Updated: July 20, 2024, 11:14 pm

Market Cap 1,19,957 Cr.
Current Price 1,486
High / Low1,582/1,038
Stock P/E28.2
Book Value 331
Dividend Yield0.88 %
ROCE23.1 %
ROE17.0 %
Face Value 2.00
PEG Ratio1.48

Data Source: screener.in

Competitors of Cipla Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
J B Chemicals & Pharmaceuticals Ltd 27,791 Cr. 1,7901,940/1,18450.3 1880.50 %25.1 %20.4 % 1.00
Astrazeneca Pharma India Ltd 15,870 Cr. 6,3487,572/3,730106 2850.38 %31.1 %22.9 % 2.00
Lyka Labs Ltd 412 Cr. 115144/97.9 17.90.00 %3.95 %6.61 % 10.0
Torrent Pharmaceuticals Ltd 99,713 Cr. 2,9463,079/1,77163.0 2030.95 %23.2 %24.2 % 5.00
Bacil Pharma Ltd 11.1 Cr. 18.929.2/4.68 2.070.00 %4.94 %5.19 % 10.0
Industry Average15,524.96 Cr1,289.1644.15207.370.35%17.15%16.41%6.53

Cipla Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales5,1694,6065,5045,5205,4795,2605,3755,8295,8105,7396,3296,6786,604
Expenses3,9383,8104,1584,2944,2484,5114,2324,5264,4034,5664,8354,9444,856
Operating Profit1,2317961,3461,2261,2317501,1431,3021,4081,1741,4941,7341,748
OPM %24%17%24%22%22%14%21%22%24%20%24%26%26%
Other Income8760-6061917103123114-48136176-10
Interest48273038211818263234162630
Depreciation248285261253247290254299272346239290233
Profit before tax1,0215449969961,0544489751,1001,2187451,3751,5941,474
Tax %26%24%28%28%28%16%28%28%34%30%28%28%28%
Net Profit7524127107097573717067978085229981,1551,068
EPS in Rs9.285.138.868.829.034.498.519.789.926.5112.3314.0113.08

Last Updated: July 11, 2024, 9:10 am

Cipla Ltd Quarterly Chart

Profit & Loss - Annual Report

Last Updated: July 10, 2024, 11:58 am

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales7,0218,27910,17311,34513,79014,39415,15616,36217,13219,16021,76322,75325,350
Expenses5,3256,0658,0269,18311,31011,89812,32913,26513,92614,90717,21117,72619,201
Operating Profit1,6962,2142,1472,1632,4802,4962,8263,0973,2064,2524,5535,0276,149
OPM %24%27%21%19%18%17%19%19%19%22%21%22%24%
Other Income10324525116420820828047734426699293255
Interest3834146168207159114168197161106110107
Depreciation3123303735057541,3231,3231,3261,1751,0681,0521,1721,109
Profit before tax1,4482,0951,8801,6541,7271,2221,6692,0792,1783,2903,4934,0385,188
Tax %21%26%25%24%19%15%15%27%29%27%27%30%
Net Profit1,1441,5451,4041,2291,3831,0351,4171,4921,5002,3892,5472,8333,743
EPS in Rs14.2519.2417.2914.7116.9312.5117.5218.9619.1829.8231.1934.7145.93
Dividend Payout %14%10%12%14%12%16%17%16%21%17%16%24%

Cipla Ltd Profit & Loss Yearly Chart

Growth

Compounded Sales Growth
10 Years:10%
5 Years:10%
3 Years:10%
TTM:13%
Compounded Profit Growth
10 Years:12%
5 Years:25%
3 Years:22%
TTM:50%
Stock Price CAGR
10 Years:13%
5 Years:22%
3 Years:16%
1 Year:47%
Return on Equity
10 Years:12%
5 Years:14%
3 Years:15%
Last Year:17%

Last Updated: July 9, 2024, 5:01 pm

Balance Sheet

Last Updated: July 10, 2024, 11:59 am

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital161161161161161161161161161161161161161
Reserves7,4788,8589,89010,64111,35612,38314,06814,85115,60218,16520,68023,24624,664
Borrowings299671,2481,7035,2024,1134,0984,3162,8162,0141,056803961
Other Liabilities1,6821,6722,1023,1664,3314,2134,3464,4334,8434,5144,9605,0895,591
Total Liabilities9,35011,65813,40015,67021,04920,86922,67323,76223,42324,85526,85729,30031,377
Fixed Assets3,2153,6106,4966,8309,3689,4929,9509,6089,6839,5169,6839,1609,397
CWIP3713784425812,0611,6839816768259697661,093791
Investments1,2692,5327096407599731,2592,5541,4712,7102,5513,6624,272
Other Assets4,4945,1385,7537,6208,8628,72110,48310,92311,44411,66113,85715,38416,917
Total Assets9,35011,65813,40015,67021,04920,86922,67323,76223,42324,85526,85729,30031,377

Cipla Ltd Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity 1,3981,5631,1731,7412,3821,4631,6913,0683,7553,3263,2384,134
Cash from Investing Activity -2,063-1,265-950-4,533-1,304-834-1,688114-2,374-1,858-2,376-2,988
Cash from Financing Activity 718-2661653,104-1,326-385-349-2,949-1,240-1,600-958-1,200
Net Cash Flow5333388312-248243-345234141-132-97-55

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days745964626575938366576568
Inventory Days295273329273239271250267232230228217
Days Payable10292126106108142123139103108109102
Cash Conversion Cycle266239267230196204220211195180184182
Working Capital Days142126133121111129143122106103122193
ROCE %24%19%15%13%7%9%11%12%17%17%18%

Cipla Ltd Financial Efficiency Indicators Chart

Share Holding Pattern

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
Promoters36.72%36.12%36.11%33.63%33.61%33.61%33.61%33.55%33.46%33.46%33.46%33.46%
FIIs24.83%24.80%24.36%26.65%27.65%27.69%28.39%27.42%25.49%25.74%25.73%25.82%
DIIs16.24%21.03%21.52%21.99%21.33%21.47%20.87%21.83%24.05%23.90%24.05%24.15%
Government0.00%0.00%0.00%0.00%0.00%0.21%0.21%0.21%0.21%0.21%0.21%0.21%
Public22.21%18.05%18.01%17.73%17.40%17.00%16.91%16.99%16.76%16.68%16.53%16.36%
No. of Shareholders4,08,4014,10,8314,51,3654,18,5844,18,9103,88,8644,04,1824,75,2934,66,5154,26,8634,25,7314,36,154

Cipla Ltd Shareholding Pattern Chart

No. of Cipla Ltd Shareholders

Cipla Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Flexi Cap Fund - Regular Plan19,000,0005.592844.213,700,0002024-07-20413.51%
HDFC ELSS Tax Saver Fund5,200,0005.56778.413,700,0002024-07-2040.54%
Parag Parikh Flexi Cap Fund4,174,1231.03624.853,700,0002024-07-2012.81%
Franklin India Focused Equity Fund3,700,0004.96553.873,700,0002024-07-200%
HDFC Focused 30 Fund - Regular Plan3,600,0005.17538.93,700,0002024-07-20-2.7%
Nippon India Pharma Fund3,100,0006.51464.053,700,0002024-07-20-16.22%
HDFC Top 100 Fund - Regular Plan2,266,2821.05339.253,700,0002024-07-20-38.75%
Aditya Birla Sun Life Frontline Equity Fund2,092,9591.17313.313,700,0002024-07-20-43.43%
Axis Bluechip Fund1,434,7720.64214.783,700,0002024-07-20-61.22%
Nippon India ETF Nifty 50 BeES1,263,3060.8189.113,700,0002024-07-20-65.86%

Cipla Ltd ROCE Trend

Cipla Ltd EPS Trend

Cipla Ltd Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue2.002.002.002.002.00
Basic EPS (Rs.)51.0534.7231.2029.8219.19
Diluted EPS (Rs.)51.0134.6931.1729.7919.16
Cash EPS (Rs.)64.4949.6544.7643.0233.76
Book Value[Excl.RevalReserv]/Share (Rs.)331.98293.79261.74230.46199.16
Book Value[Incl.RevalReserv]/Share (Rs.)331.98293.79261.74230.46199.16
Revenue From Operations / Share (Rs.)319.24281.89269.75237.58212.49
PBDIT / Share (Rs.)87.1768.1759.9156.0344.03
PBIT / Share (Rs.)74.1553.6546.8742.7929.46
PBT / Share (Rs.)70.6250.0343.3040.8027.02
Net Profit / Share (Rs.)51.4735.1331.7229.7819.19
NP After MI And SOA / Share (Rs.)51.0534.7131.1929.8219.18
PBDIT Margin (%)27.3024.1822.2123.5820.72
PBIT Margin (%)23.2219.0317.3718.0113.86
PBT Margin (%)22.1217.7416.0517.1712.71
Net Profit Margin (%)16.1212.4611.7612.539.02
NP After MI And SOA Margin (%)15.9912.3111.5612.559.02
Return on Networth / Equity (%)15.4311.9612.0713.129.81
Return on Capital Employeed (%)21.7917.7817.0416.7812.32
Return On Assets (%)12.599.509.289.566.53
Long Term Debt / Equity (X)0.000.000.010.060.15
Total Debt / Equity (X)0.010.020.030.080.17
Asset Turnover Ratio (%)0.820.570.510.590.57
Current Ratio (X)3.713.383.002.882.66
Quick Ratio (X)2.712.371.911.861.67
Inventory Turnover Ratio (X)1.000.810.700.870.85
Dividend Payout Ratio (NP) (%)0.000.000.000.0036.48
Dividend Payout Ratio (CP) (%)0.000.000.000.0020.73
Earning Retention Ratio (%)0.000.000.000.0063.52
Cash Earning Retention Ratio (%)0.000.000.000.0079.27
Interest Coverage Ratio (X)78.3050.2345.4528.1217.99
Interest Coverage Ratio (Post Tax) (X)49.4028.5526.7815.948.84
Enterprise Value (Cr.)120138.5271957.4681343.9366141.1536211.18
EV / Net Operating Revenue (X)4.663.163.743.452.11
EV / EBITDA (X)17.0713.0816.8314.6410.20
MarketCap / Net Operating Revenue (X)4.683.193.783.431.99
Retention Ratios (%)0.000.000.000.0063.51
Price / BV (X)4.523.113.943.592.16
Price / Net Operating Revenue (X)4.683.193.783.431.99
EarningsYield0.030.030.030.030.04

Cipla Ltd Profitability Ratios (%)

Cipla Ltd Liquidity Ratios

Cipla Ltd Liquidity Ratios (%)

Cipla Ltd Interest Coverage Ratios (%)

Cipla Ltd Valuation Ratios

Fair Value

Fair Value: 1,600.78

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 7.72% compared to the current price 1486

Intrinsic Value: 1,906.25

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 28.28% compared to the current price 1486

Last 5 Year EPS CAGR: 19.08%

*Investments are subject to market risks

Strength and Weakness of Cipla Ltd Stock

StrengthWeakness
  1. The company has higher reserves (15,523.75 cr) compared to borrowings (2,407.92 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (15.23 cr) and profit (2.08 cr) over the years.
  1. The stock has a low average ROCE of 13.50%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 129.25, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 214.50, which may not be favorable.

Should I Buy Cipla Ltd Stock Now?

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cipla Ltd:
    1. Net Profit Margin: 16.12%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 21.79% (Industry Average ROCE: %)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 15.43% (Industry Average ROE: %)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 49.40
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 2.71
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 28.2 (Industry average Stock P/E: )
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.01
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

FAQ

What is the latest fair value of Cipla Ltd?

The latest fair value of Cipla Ltd is ₹1600.78.

What is the Market Cap of Cipla Ltd?

The Market Cap of Cipla Ltd is 1,19,957 Cr..

What is the current Stock Price of Cipla Ltd as on 21 July 2024?

The current stock price of Cipla Ltd as on 21 July 2024 is 1,486.

What is the High / Low of Cipla Ltd stocks in FY 2024?

In FY 2024, the High / Low of Cipla Ltd stocks is 1,582/1,038.

What is the Stock P/E of Cipla Ltd?

The Stock P/E of Cipla Ltd is 28.2.

What is the Book Value of Cipla Ltd?

The Book Value of Cipla Ltd is 331.

What is the Dividend Yield of Cipla Ltd?

The Dividend Yield of Cipla Ltd is 0.88 %.

What is the ROCE of Cipla Ltd?

The ROCE of Cipla Ltd is 23.1 %.

What is the ROE of Cipla Ltd?

The ROE of Cipla Ltd is 17.0 %.

What is the Face Value of Cipla Ltd?

The Face Value of Cipla Ltd is 2.00.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Cipla Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE